Abstract
Bovine ephemeral fever (BEF) is an arthropod‑borne viral disease characterised by a short‑term clinical expression that can lead to significant losses in high‑yielding cattle and water buffaloes. In this study, we aimed to generate a recombinant plasmid expressing the glycoprotein (G) of the BEF virus (BEFV) and to stimulate a humoral immune response to this protein in BALB / c mice immunised with the recombinant plasmid. Expression of the encoded protein was demonstrated by western blotting and immunoperoxidase tests. The suitable plasmids were intramuscularly administered to BALB/c mice on days 0, 14 and 21. The antibody response in the immunised mice was measured by a plaque reduction neutralization test (PRNT) and enzyme‑linked immunosorbent assay (ELISA). According to BEFV ELISA, only two of the seven animals in these groups exceeded the cut‑off value. A significant difference was observed in the mean OD values at 450 nm absorbance in the pcDNA4‑G‑immunised group when compared with those in the plasmid control group at 30 days (p < 0.05). According to PRNT50 results, a 1:20 (p < 0.05) antibody response was obtained at 30 days in pcDNA4‑G (100 μg)‑immunised mice, whereas this ratio was 1:80 (p < 0.001) in BEFV‑immunised mice (1,000 PFU/0.5 ml). We conclude that the humoral immune response was stimulated in experimental mice immunised with the recombinant plasmid. However, disappointingly, the antibody response was markedly low in pcDNA4‑G‑immunised mice.
References
Abayli H., Tonbak S., Azkur A.K. & Bulut H. 2017. Complete genome analysis of highly pathogenic bovine ephemeral fever virus isolated in Turkey in 2012. Arch Virol, 162, 3233-3238.
Aziz-Boaron O., Gleser D., Yadin H., Gelman B., Kedmi M., Galon N. & Klement E. 2014. The protective effectiveness of an inactivated bovine ephemeral fever virus vaccine. Vet Microbiol, 173, 1-8.
Aziz-Boaron O., Leibovitz K., Gelman B., Kedmi M. & Klement E. 2013. Safety, immunogenity and duration of immunity elicited by an inactivated bovine ephemeral fever vaccine. PLOS One, 8, e82217.
Bulut H. & Azkur A.K. 2016. Bovine ephemeral fever virus. In Molecular detection of animal viral pathogens. (D. Liu, ed.). CRC Press, Boca Raton, 355-358.
Davis S.S., Gibson D.S. & Clark R. 1984. The effect of bovine ephemeral fever on milk production. Aust Vet J, 61, 128.
Della-Porta A.J. & Snowdon W.A. 1979. An experimental inactivated virus vaccine against bovine ephemeral fever 2. Do neutralizing antibodies protect against infection? Vet Microbiol, 4, 197-208.
Hertig C., Pye A.D., Hyatt A.D., Davis S.S., McWilliam S.M., Heine H.G., Walker P.J. & Boyle D.B. 1996. Vaccinia virus-expressed bovine ephemeral fever virus G but not Gns glycoprotein induces neutralizing antibodies and protects against experimental infection. J Gen Virol, 77, 631-640.
Lodmell D.L., Ray N.B., Parnel M.J., Ewalt L.C., Hanlon C.A., Shaddock J.H., Sanderlin D.S. & Rupprecht C.E. 1998. DNA immunization protects non-human primates against rabies virus. Nat Med, 4, 949-952.
Nandi S. & Negi B.S. 1999. Bovine ephemeral fever: a review. Comp Immunol Microbiol Infect Dis, 22, 81-91.
Pereira V.B., Zurita-Turk M., Saraiva T.D.L., De Castro C.P., Souza B.M., Agresti P.M., Lima F.A., Pfeiffer V.N., Azevedo M.S.P., Rocha C.S., Pontes D.S., Azevedo V. & Miyoshi A. 2014. DNA vaccines approach: from concepts to applications. World J Vaccines, 4, 50-71.
Redding L. & Weiner D.B. 2009. DNA vaccines in veterinary use. Expert Rev Vaccines, 8, 1251-1276.
Sharma A.K. & Khuller G.K. 2001. DNA vaccines: future strategies and relevance to intracelluler pathogens. Immunol Cell Biol, 79, 537-546.
Spradbrow P.B. 1975. Attenuated vaccines against bovine ephemeral fever. Aust Vet J, 10, 464-468.
St George T.D., Murphy G.M., Buren B. & Uren M.F. 1995. Studies on the pathogenesis of bovine ephemeral fever IV: A comparison with the inflammatory events in milk fever of cattle. Vet Microbiol, 46, 131-142.
ST George T.D., Uren M.F. & Zakrzewski H. The pathogenesis and treatment of bovine ephemeral fever. In Arbovirus Research in Australia. Proc Fourth Symposium, Brisbane, 6-9 May 1986. CSIRO Division of Tropical Animal Science, Brisbane, 303-307.
St George T.D. 1988. Bovine ephemeral fever: a review. Trop Anim Health Prod, 20, 194-202.
Stachyra A., Góra-Sochacka A. & Sirko A. 2014. DNA vaccines against influenza. Acta Biochim Pol, 61, 515-522.
Tonbak S., Berber E., Yoruk M.D., Azkur A.K., Pestil Z. & Bulut H. 2013. A large-scale outbreak of bovine ephemeral fever in Turkey, 2012. J Vet Med Sci, 75, 1511-1514.
Tzipori S & Spradbrow P.B. 1973. Studies on vaccines against bovine ephemeral fever. Aust Vet J, 49, 183-187.
Uren M.F. 1989. Bovine Ephemeral Fever. Aust Vet J, 66, 233-236.
Uren M.F., Walker P.J., Zakrzewski H., St George T.D. & Byrne K.A. 1994. Effective vaccination of cattle using the virion G protein of bovine ephemeral fever virus as an antigen. Vaccine, 12, 845-850.
Vanselow B.A., Walthall J.C. & Abetz I. 1995. Field trials of ephemeral fever vaccines. Vet Microbiol, 46, 117-130.
Walker P.J. 2009. Bovine Ephemeral Fever Virus. In Desk Encyclopedia of Animal and Bacterial Virology, 2nd Ed. (B.W.J. Mahy & M.H.V. Van Regenmortel, eds). Academic Press, San Diego, 57-65.
Walker P.J. & Klement E. 2015. Epidemiology and control of bovine ephemeral fever. Vet Res, 46, 124.
Wallace D.B. & Viljoen G.J. 2005. Immune responses to recombinants of the South African vaccine strain of lumpy skin disease virus generated by using thymidine kinase gene insertion. Vaccine, 23, 3061-3067.
Wang G., Pan L. & Zhang Y. 2011. Approaches to improved targeting of DNA vaccines. Hum Vaccin, 7, 1271-1281.
Wang S., Zhang C., Li J., Huang Z. & Lu S. 2008. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine, 26, 2100-2110.
Zhang M., Ge J., Wen Z., Chen W., Wang X., Liu R. & Bu Z. 2017. Characterization of recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus. Arch Virol, 162, 359-367.